One Nation is now more popular than the Coalition, polls reveal
In the latest polls, Labor leads in Newspoll by 55–45 but only by 52–48 in Resolve. In Newspoll, Labor has 32% of the primary vote,...
In the latest polls, Labor leads in Newspoll by 55–45 but only by 52–48 in Resolve. In Newspoll, Labor has 32% of the primary vote,...
An Artificial Intelligence bus is hurtling down our information superhighway and employees will be the casualties.
While CSL has become a real head scratcher, a fall in its share price is understandable. But has the fall been excessive? Its sell off…
Although I’ve never been a gold bug, I have been investing in gold over the last few months. Let me explain how I invest in…
In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk explains why the Morgan’s team maintains a buy rating on Amcor…
Here are four biotech ETFs for long-term contrarian investors to consider.
Every investor is looking for meaningful capital gain when they buy a stock. Here are two candidates that look capable of delivering that in 2026.
For the week ending Friday 16 January 2026, FNArena registered no less than 15 upgrades in ratings for ASX-listed stocks.
On this kick-off ep for the new year, we're looking at roughed-up companies on the market that might be worth a second look. Quality stocks...
On this kick-off ep for the new year, we’re looking at roughed-up companies on the market that might be worth a second look. Quality stocks…
Two weeks of data drops will determine if the rate rise story is right
For market players, 2026 (just like 2025) is set to be the same as it was overnight — Trump-v-the economy, with AI remaining both the…